» Articles » PMID: 15557603

Vesicular Transport is Not Required for the Cytoplasmic Pool of Cholera Toxin to Interact with the Stimulatory Alpha Subunit of the Heterotrimeric G Protein

Overview
Journal Infect Immun
Date 2004 Nov 24
PMID 15557603
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Cholera toxin (CT) moves from the cell surface to the endoplasmic reticulum (ER) by retrograde vesicular transport. The catalytic A1 polypeptide of CT (CTA1) then crosses the ER membrane, enters the cytosol, ADP-ribosylates the stimulatory alpha subunit of the heterotrimeric G protein (Gsalpha) at the cytoplasmic face of the plasma membrane, and activates adenylate cyclase. The cytosolic pool of CTA1 may reach the plasma membrane and its Gsalpha target by traveling on anterograde-directed transport vesicles. We examined this possibility with the use of a plasmid-based transfection system that directed newly synthesized CTA1 to either the ER lumen or the cytosol of CHO cells. Such a system allowed us to bypass the CT retrograde trafficking itinerary from the cell surface to the ER. Previous work has shown that the ER-localized pool of CTA1 is rapidly exported from the ER to the cytosol. Expression of CTA1 in either the ER or the cytosol led to the activation of Gsalpha, and Gsalpha activation was not inhibited in transfected cells exposed to drugs that inhibit vesicular traffic. Thus, anterograde transport from the ER to the plasma membrane is not required for the cytotoxic action of CTA1.

Citing Articles

The cytopathic activity of cholera toxin requires a threshold quantity of cytosolic toxin.

Bader C, Taylor M, Banerjee T, Teter K Cell Signal. 2022; 101:110520.

PMID: 36371029 PMC: 9722578. DOI: 10.1016/j.cellsig.2022.110520.


Quercetin-3-Rutinoside Blocks the Disassembly of Cholera Toxin by Protein Disulfide Isomerase.

Guyette J, Cherubin P, Serrano A, Taylor M, Abedin F, ODonnell M Toxins (Basel). 2019; 11(8).

PMID: 31382673 PMC: 6722528. DOI: 10.3390/toxins11080458.


A binding motif for Hsp90 in the A chains of ADP-ribosylating toxins that move from the endoplasmic reticulum to the cytosol.

Kellner A, Taylor M, Banerjee T, Britt C, Teter K Cell Microbiol. 2019; 21(10):e13074.

PMID: 31231933 PMC: 6744307. DOI: 10.1111/cmi.13074.


Inhibition of Cholera Toxin and Other AB Toxins by Polyphenolic Compounds.

Cherubin P, Garcia M, Curtis D, Britt C, Craft Jr J, Burress H PLoS One. 2016; 11(11):e0166477.

PMID: 27829022 PMC: 5102367. DOI: 10.1371/journal.pone.0166477.


Thermal Unfolding of the Pertussis Toxin S1 Subunit Facilitates Toxin Translocation to the Cytosol by the Mechanism of Endoplasmic Reticulum-Associated Degradation.

Banerjee T, Cilenti L, Taylor M, Showman A, Tatulian S, Teter K Infect Immun. 2016; 84(12):3388-3398.

PMID: 27647866 PMC: 5116717. DOI: 10.1128/IAI.00732-16.


References
1.
Lencer W, de Almeida J, Moe S, Stow J, Ausiello D, Madara J . Entry of cholera toxin into polarized human intestinal epithelial cells. Identification of an early brefeldin A sensitive event required for A1-peptide generation. J Clin Invest. 1993; 92(6):2941-51. PMC: 288498. DOI: 10.1172/JCI116917. View

2.
Schmitz A, Herrgen H, Winkeler A, Herzog V . Cholera toxin is exported from microsomes by the Sec61p complex. J Cell Biol. 2000; 148(6):1203-12. PMC: 2174307. DOI: 10.1083/jcb.148.6.1203. View

3.
Teter K, Allyn R, Jobling M, Holmes R . Transfer of the cholera toxin A1 polypeptide from the endoplasmic reticulum to the cytosol is a rapid process facilitated by the endoplasmic reticulum-associated degradation pathway. Infect Immun. 2002; 70(11):6166-71. PMC: 130427. DOI: 10.1128/IAI.70.11.6166-6171.2002. View

4.
Jobling M, Holmes R . Biological and biochemical characterization of variant A subunits of cholera toxin constructed by site-directed mutagenesis. J Bacteriol. 2001; 183(13):4024-32. PMC: 95286. DOI: 10.1128/JB.183.13.4024-4032.2001. View

5.
Nambiar M, Oda T, Chen C, Kuwazuru Y, Wu H . Involvement of the Golgi region in the intracellular trafficking of cholera toxin. J Cell Physiol. 1993; 154(2):222-8. DOI: 10.1002/jcp.1041540203. View